Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03634332
Title Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Pancreatic Cancer Research Team
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.